HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Izumi Takeyoshi Selected Research

ONO-LB 457

12/2009Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Izumi Takeyoshi Research Topics

Disease

34Neoplasms (Cancer)
10/2016 - 11/2002
25Reperfusion Injury
08/2011 - 01/2001
17Breast Neoplasms (Breast Cancer)
01/2017 - 04/2008
16Ischemia
08/2011 - 09/2002
9Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 01/2004
9Stomach Neoplasms (Stomach Cancer)
01/2013 - 01/2002
8Lung Neoplasms (Lung Cancer)
01/2017 - 06/2009
7Neoplasm Metastasis (Metastasis)
05/2014 - 01/2009
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 01/2010
6Carcinoma (Carcinomatosis)
01/2016 - 07/2010
6Adenocarcinoma of Lung
01/2016 - 01/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
02/2015 - 11/2008
5Flushing
03/2007 - 02/2002
4Ascites
06/2012 - 07/2005
4Heart Arrest (Cardiac Arrest)
03/2007 - 01/2001
3Lymphatic Metastasis
09/2015 - 11/2012
3Sarcoma (Soft Tissue Sarcoma)
06/2015 - 03/2014
3Rectal Neoplasms (Rectal Cancer)
01/2015 - 09/2003
3Adenocarcinoma
03/2014 - 07/2010
3Arteriosclerosis
11/2004 - 01/2003
2Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2014 - 10/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2014 - 07/2010
2Adenoma (Adenomas)
01/2014 - 04/2012
2Cushing Syndrome
01/2014 - 04/2012
2Chronic Kidney Failure (Chronic Renal Failure)
06/2007 - 08/2006

Drug/Important Bio-Agent (IBA)

11ErbB Receptors (EGF Receptor)IBA
01/2017 - 03/2010
10Paclitaxel (Taxol)FDA LinkGeneric
09/2015 - 01/2005
7Estrogen ReceptorsIBA
09/2016 - 03/2011
7Proteins (Proteins, Gene)FDA Link
01/2016 - 04/2006
6SolutionsIBA
03/2007 - 01/2001
6CelsiorIBA
03/2007 - 01/2001
5Messenger RNA (mRNA)IBA
09/2016 - 10/2006
5doxifluridineIBA
12/2011 - 01/2005
5FR 167653IBA
03/2009 - 08/2002
5p38 Mitogen-Activated Protein KinasesIBA
03/2007 - 03/2002
4Amino Acid Transport Systems (Amino Acid Transporter)IBA
09/2015 - 10/2013
4FK 3311IBA
05/2007 - 11/2003
4FR 173657IBA
01/2005 - 09/2002
3Indicators and Reagents (Reagents)IBA
01/2017 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
09/2016 - 09/2011
3Estrogens (Estrogen)FDA Link
01/2016 - 04/2008
3Biomarkers (Surrogate Marker)IBA
01/2016 - 10/2013
3Progesterone Receptors (Progesterone Receptor)IBA
01/2016 - 03/2011
3Trastuzumab (Herceptin)FDA Link
09/2015 - 02/2009
3Fluorouracil (Carac)FDA LinkGeneric
09/2015 - 08/2005
3Biological ProductsIBA
12/2014 - 01/2005
3Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2014 - 11/2008
3GemcitabineFDA Link
10/2013 - 11/2002
3AnthracyclinesIBA
01/2013 - 02/2009
3human ERBB2 proteinIBA
01/2013 - 09/2011
3CytokinesIBA
10/2010 - 03/2006
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2007 - 11/2003
3BradykininIBA
01/2005 - 09/2002
2Tyrosine Kinase InhibitorsIBA
02/2016 - 01/2010
2Aromatase (CYP19)IBA
01/2016 - 06/2009
2Taxoids (Taxanes)IBA
09/2015 - 01/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 09/2013
2Amino AcidsFDA Link
09/2015 - 01/2015
2Matrix Metalloproteinases (MMPs)IBA
01/2015 - 06/2012
2Codon (Codons)IBA
09/2014 - 01/2010
2Capecitabine (Xeloda)FDA Link
06/2014 - 11/2008
2Bevacizumab (Avastin)FDA Link
06/2014 - 05/2014
2Tumor Biomarkers (Tumor Markers)IBA
05/2014 - 01/2009
2Carcinoembryonic AntigenIBA
05/2014 - 04/2013
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2014 - 04/2012
2AldosteroneIBA
01/2014 - 04/2012
2TegafurIBA
12/2013 - 04/2006
2UracilIBA
12/2013 - 04/2006
2polysaccharide-KIBA
12/2013 - 04/2006
2Pharmaceutical PreparationsIBA
01/2013 - 08/2011
2Formaldehyde (Formol)FDA Link
10/2012 - 03/2010
2Epidermal Growth Factor (EGF)IBA
10/2012 - 03/2009
2ParaffinIBA
10/2012 - 03/2010
2Immunoglobulin G (IgG)IBA
09/2012 - 01/2005
2lysophosphatidic acidIBA
06/2012 - 03/2009
2Glyburide (Glibenclamide)FDA LinkGeneric
08/2011 - 05/2011
2Nicorandil (SG 75)IBA
08/2011 - 05/2011
2Adenosine Triphosphate (ATP)IBA
08/2011 - 05/2011
2NitratesIBA
08/2011 - 05/2011
2Chromogranin AIBA
03/2011 - 12/2006
2Polymyxin B (Aerosporin)FDA LinkGeneric
09/2009 - 05/2008
2Arachidonic Acid (Vitamin F)IBA
05/2007 - 01/2005
2Free Radical ScavengersIBA
08/2006 - 09/2005
2EdaravoneIBA
08/2006 - 09/2005
2Mitogen-Activated Protein KinasesIBA
03/2006 - 03/2002

Therapy/Procedure

19Therapeutics
06/2015 - 11/2002
17Drug Therapy (Chemotherapy)
09/2015 - 01/2005
8Warm Ischemia
08/2011 - 01/2001
5Transplantation
03/2009 - 01/2003
3Adjuvant Chemotherapy
10/2016 - 04/2008
3Neoadjuvant Therapy
09/2015 - 09/2011
3Thoracotomy
12/2012 - 05/2008
3Combination Drug Therapy (Combination Chemotherapy)
01/2011 - 08/2005
3Lung Transplantation
05/2004 - 01/2001
2Segmental Mastectomy (Lumpectomy)
01/2015 - 06/2009
2Metastasectomy
05/2014 - 04/2013
2Hemoperfusion
09/2009 - 05/2008
2Gastrectomy
01/2009 - 12/2006
2Laparotomy
10/2008 - 01/2002
2Renal Dialysis (Hemodialysis)
06/2007 - 08/2006